AMENDMENT NO. 2 TO THE CREDIT AGREEMENTThe Credit Agreement • May 9th, 2023 • Halozyme Therapeutics, Inc. • Biological products, (no disgnostic substances)
AMENDMENT NO. 2 to the CREDIT AGREEMENT, dated as of March 1, 2023 (this “Amendment”), is made by and among HALOZYME THERAPEUTICS, INC., a Delaware corporation (the “Borrower”) and BANK OF AMERICA, N.A., as administrative agent (in such capacity, the “Administrative Agent”).
